Anzeige
Mehr »
Freitag, 09.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
106 Leser
Artikel bewerten:
(0)

Transonic Systems Selects Infinity Info Systems To Implement Microsoft Dynamics CRM To Drive Business Performance And Operational Excellence

NEW YORK, June 29, 2012 /PRNewswire/ --Infinity Info Systems, a premier provider of customer relationship management (CRM) and business analytics solutions with deep industry expertise in Life Sciences and Complex Manufacturing, was recently selected by Transonic Systems', the industry leader in biomedical flow measurement innovation and quality, to implement their Microsoft Dynamics CRM® On-Premise solution.

Transonic Systems was looking to implement a CRM solution to improve overall business performance and enable their sales force to work more efficiently in the field by allowing them to make smarter decisions based on actionable data from within their system. The goal was to have this new CRM solution in place and implemented prior to their Global Sales Meeting in August 2012.

Using Microsoft Dynamics CRM On-Premise, Transonic will have the ability to:

  • Track opportunities, pipeline and activities worldwide
  • Use dashboards to provide visual representations specific to business unit
  • Migrate from a traditional legacy system to Microsoft Dynamics CRM, creating a platform for future growth and deployment to Marketing & Customer Service
  • Integrate with Macola to see quotes within contact records, providing a 360 degree view of a client
  • Integrate with HubSpot to track ROI from their Inbound Marketing programs

"With Infinity's deep expertise in the Life Sciences Industry and their technology expertise as a Microsoft Gold Certified Business Solutions partner in Microsoft Dynamics CRM, we knew we were choosing a CRM platform that was both scalable and flexible, allowing us to reduce our development costs and allowing our organization to quickly adapt to the rapid changes and growth of the marketplace and our client base," said Andrew Bloom, Transonic's World-Wide Vice President of Sales.

"We were thrilled to be chosen by Transonic as their premier consulting partner to help them in their Microsoft Dynamics CRM deployment," said Nicole Lucarelli, Senior Account Executive Life Sciences and Manufacturing at Infinity Info Systems. "Transonic's continuous focus on innovation and on pioneering advances in measurement instrumentation has enabled them to become the gold standard in cardiovascular surgery, research and hemodialysis. This aligns well with Infinity's focus on market leading industry Life Science solutions which is a key differentiator on how we like to partner and work with our clients."

About Infinity Info Systems
Founded in 1987, Infinity Info Systems develops customer relationship management (CRM) and business analytics solutions for clients in the financial services, life sciences, business services, media and manufacturing/distribution industries around the world.Infinity's technology solutions, services, training and support help organizations become more profitable by improving sales, marketing and customer service effectiveness. Infinity has trained more than 130,000 professionals and successfully implemented more than 3,500 CRM systems. For more information contact us at 800.354.4228 or visit us online at www.infinityinfo.com or connect with us on Facebook, Twitter and join our Community.

About Transonic Systems Inc.
R&D Scientist and Engineer Cornelis J. Drost founded Transonic Systems Inc in 1983 after inventing the transit time ultrasound flowmeter for vascular applications -- the first ever to measure volume flow in blood vessels -- while working as a Senior Research Scientist at Cornell University in Ithaca NY. Transonic quickly became the "Gold Standard" in cardiovascular research, then in surgical applications worldwide. As the company progressed, new flow measurement innovations were added in fields such as Hemodialysis, Critical Care, Surgery, ECMO, and Ventricular Assist Devices, and Transonic has now grown to become recognized as a solutions innovator and applications specialist for all biomedical flow measurement challenges. In addition to its ultrasound transit-time and indicator dilution flow measurements, Transonic offers Laser Doppler Meters for Perfusion Monitoring, as well as a full range of implantable biotelemetry measurement solutions and pressure & pressure/volume systems for the life sciences.

SOURCE Infinity Info Systems

© 2012 PR Newswire
Renditeturbo 2026 - 5 Aktien mit Potenzial
2025 neigt sich dem Ende zu, ohne klassische Jahresendrallye, aber mit einem DAX, der viele Kritiker Lügen gestraft hat. Über 21 Prozent Kursplus seit Jahresbeginn, stärker als der US-Markt. Wer hätte das noch vor Monaten erwartet?

Genau solche Entwicklungen machen den Reiz der Börse aus. Denn auch 2026 dürfte wieder alles anders kommen als gedacht. Während viele Analysten weiter steigende Kurse erwarten, rückt eine zentrale Frage in den Fokus: Wo entstehen im kommenden Jahr echte Überraschungen, und wie kann man davon profitieren?

Unser aktueller Spezialreport beleuchtet fünf Entwicklungen, mit denen kaum jemand rechnet, die aber enormes Renditepotenzial bergen. Vom Comeback der Ölwerte über unterschätzte Plattform-Aktien bis hin zur möglichen Wachablösung im KI-Sektor: Wer 2026 überdurchschnittlich abschneiden will, muss antizyklisch denken und frühzeitig Position beziehen.

Im kostenlosen Report stellen wir 5 Aktien vor, die 2026 im Zentrum solcher Wendepunkte stehen könnten. Solide bewertet, gut positioniert und mit überraschend starkem Momentum.

Jetzt kostenlos herunterladen! Bevor andere erkennen, wo die Chancen wirklich liegen!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.